Literature DB >> 18443296

Selective targeting of ITK blocks multiple steps of HIV replication.

Julie A Readinger1, Gillian M Schiralli, Jian-Kang Jiang, Craig J Thomas, Avery August, Andrew J Henderson, Pamela L Schwartzberg.   

Abstract

Treatment for HIV has relied on the use of antiretroviral agents that can be subject to the development of resistant viruses. The study of inhibitors directed against cellular proteins required for HIV replication is therefore of growing interest. Inducible T cell kinase (ITK) is a Tec family tyrosine kinase that regulates T cell receptor (TCR)-induced activation of PLCgamma-1, Ca(2+) mobilization and transcription factor activation, and actin rearrangement downstream of both TCR and chemokine receptors. Because productive infection of T cells with HIV requires T cell activation, chemokine receptors and actin reorganization, we asked whether ITK affects HIV infection using ITK-specific siRNA, a kinase-inactive ITK mutant or an ITK inhibitor. We demonstrate that loss of ITK function resulted in marked reductions in intracellular p24 levels upon HIV infection. Loss of ITK function after establishment of HIV infection also decreased virus spread within the culture. Inhibition of ITK did not affect expression of the HIV coreceptors CD4 or CXCR4 but partially blocked HIV viral entry, an effect that correlated with decreased actin polarization to gp120. Additionally, ITK was required for efficient HIV transcription, and overexpression of ITK increased both viral transcription and virus-like particle formation. Our data suggest that inhibition of ITK blocks HIV infection by affecting multiple steps of HIV replication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18443296      PMCID: PMC2365562          DOI: 10.1073/pnas.0709659105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  A quantitative assay for HIV DNA integration in vivo.

Authors:  S L Butler; M S Hansen; F D Bushman
Journal:  Nat Med       Date:  2001-05       Impact factor: 53.440

2.  Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1.

Authors:  A Fassati; S P Goff
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  CCR5, CXCR4, and CD4 are clustered and closely apposed on microvilli of human macrophages and T cells.

Authors:  I I Singer; S Scott; D W Kawka; J Chin; B L Daugherty; J A DeMartino; J DiSalvo; S L Gould; J E Lineberger; L Malkowitz; M D Miller; L Mitnaul; S J Siciliano; M J Staruch; H R Williams; H J Zweerink; M S Springer
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells.

Authors:  D J Fowell; K Shinkai; X C Liao; A M Beebe; R L Coffman; D R Littman; R M Locksley
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

5.  Mutation of Tec family kinases alters T helper cell differentiation.

Authors:  E M Schaeffer; G S Yap; C M Lewis; M J Czar; D W McVicar; A W Cheever; A Sher; P L Schwartzberg
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

6.  Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA.

Authors:  Y Wu; J W Marsh
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

7.  Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A.

Authors:  Kristine N Brazin; Robert J Mallis; D Bruce Fulton; Amy H Andreotti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

8.  Identification of host proteins required for HIV infection through a functional genomic screen.

Authors:  Abraham L Brass; Derek M Dykxhoorn; Yair Benita; Nan Yan; Alan Engelman; Ramnik J Xavier; Judy Lieberman; Stephen J Elledge
Journal:  Science       Date:  2008-01-10       Impact factor: 47.728

9.  Codon usage optimization of HIV type 1 subtype C gag, pol, env, and nef genes: in vitro expression and immune responses in DNA-vaccinated mice.

Authors:  Feng Gao; Yingying Li; Julie M Decker; Fred W Peyerl; Frederic Bibollet-Ruche; Cynthia M Rodenburg; Yalu Chen; Denise R Shaw; Susan Allen; Rosemary Musonda; George M Shaw; Allan J Zajac; Norman Letvin; Beatrice H Hahn
Journal:  AIDS Res Hum Retroviruses       Date:  2003-09       Impact factor: 2.205

10.  Presence of host ICAM-1 in human immunodeficiency virus type 1 virions increases productive infection of CD4+ T lymphocytes by favoring cytosolic delivery of viral material.

Authors:  Mélanie R Tardif; Michel J Tremblay
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more
  34 in total

Review 1.  Integrin signalling and function in immune cells.

Authors:  Yanbo Zhang; Hongyan Wang
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

2.  Dynamics of the Tec-family tyrosine kinase SH3 domains.

Authors:  Justin M Roberts; Sreya Tarafdar; Raji E Joseph; Amy H Andreotti; Thomas E Smithgall; John R Engen; Thomas E Wales
Journal:  Protein Sci       Date:  2016-03-18       Impact factor: 6.725

3.  Tight-Binding Hydroxypyrazole HIV-1 Nef Inhibitors Suppress Viral Replication in Donor Mononuclear Cells and Reverse Nef-Mediated MHC-I Downregulation.

Authors:  Haibin Shi; Colin M Tice; Lori Emert-Sedlak; Li Chen; Wing Fai Li; Marianne Carlsen; Jay E Wrobel; Allen B Reitz; Thomas E Smithgall
Journal:  ACS Infect Dis       Date:  2019-12-16       Impact factor: 5.084

4.  Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells.

Authors:  Malini Natarajan; Avery August; Andrew J Henderson
Journal:  J Biol Chem       Date:  2010-04-05       Impact factor: 5.157

Review 5.  Structure, function, and inhibitor targeting of HIV-1 Nef-effector kinase complexes.

Authors:  Ryan P Staudt; John J Alvarado; Lori A Emert-Sedlak; Haibin Shi; Sherry T Shu; Thomas E Wales; John R Engen; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-08-29       Impact factor: 5.157

6.  Nef homodimers down-regulate SERINC5 by AP-2-mediated endocytosis to promote HIV-1 infectivity.

Authors:  Ryan P Staudt; Thomas E Smithgall
Journal:  J Biol Chem       Date:  2020-09-01       Impact factor: 5.157

7.  Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes.

Authors:  Jason A Dubovsky; Kyle A Beckwith; Gayathri Natarajan; Jennifer A Woyach; Samantha Jaglowski; Yiming Zhong; Joshua D Hessler; Ta-Ming Liu; Betty Y Chang; Karilyn M Larkin; Matthew R Stefanovski; Danielle L Chappell; Frank W Frissora; Lisa L Smith; Kelly A Smucker; Joseph M Flynn; Jeffrey A Jones; Leslie A Andritsos; Kami Maddocks; Amy M Lehman; Richard Furman; Jeff Sharman; Anjali Mishra; Michael A Caligiuri; Abhay R Satoskar; Joseph J Buggy; Natarajan Muthusamy; Amy J Johnson; John C Byrd
Journal:  Blood       Date:  2013-07-25       Impact factor: 22.113

8.  Molecular characteristics of CTA056, a novel interleukin-2-inducible T-cell kinase inhibitor that selectively targets malignant T cells and modulates oncomirs.

Authors:  Wenchang Guo; Ruiwu Liu; Yoko Ono; Ai-Hong Ma; Anthony Martinez; Eduardo Sanchez; Yan Wang; Wenzhe Huang; Anisha Mazloom; Jixian Li; Jinying Ning; Emanual Maverakis; Kit S Lam; Hsing-Jien Kung
Journal:  Mol Pharmacol       Date:  2012-08-16       Impact factor: 4.436

Review 9.  Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk.

Authors:  Julie A Readinger; Kristen L Mueller; Ana M Venegas; Reiko Horai; Pamela L Schwartzberg
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

10.  Proteasome inactivation promotes p38 mitogen-activated protein kinase-dependent phosphatidylinositol 3-kinase activation and increases interleukin-8 production in retinal pigment epithelial cells.

Authors:  Alexandre F Fernandes; Qingning Bian; Jian-Kang Jiang; Craig J Thomas; Allen Taylor; Paulo Pereira; Fu Shang
Journal:  Mol Biol Cell       Date:  2009-07-01       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.